Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction

Chinese Medical Journal

Volumn 122, Issue 7, 2009, Pages 802-806

  Dai, Shi Mo ^a   Zhang, Shu ^a   Chen, Ke Ping ^a   Hua, Wei ^a   Wang, Fang Zheng ^a   Chen, Xin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Cardiac; Death; Heart failure; Myocardial infarction; Sudden

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; RISK ASSESSMENT; SUDDEN DEATH; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; AMIODARONE; ANGIOPLASTY, BALLOON; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; CAUSE OF DEATH; CORONARY ARTERY BYPASS; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 68249154738     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.07.008     Document Type: Article

References (20)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-1940.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1882-1890.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. Multicenter Automatic Defibrillator Implantation Trial II Investigators. N Engl J Med 2002; 346: 877-883.
4. Huikuri HV, Mäkikallio TH, Raatikainen MJ, Perkiämäki J, Castellanos A, Myerburg RJ. Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation 2003; 108: 110-115.
5. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized controlled trials. Ann Intern Med 2003; 138: 445-452.
6. Buxton AE. The clinical use of implantable cardioverter defibrillators: where are we now? where should we go? Ann Intern Med 2003; 138: 512-514.
7. Reynolds MR, Josephson ME. MADIT II (Second multicenter automated defibrillator implantation trial) debate: risk stratification, costs, and public policy. Circulation 2003; 108: 1779-1783.
8. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML, et al. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004; 43: 1459-1465.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
10. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187-220.
11. Nicod P, Gilpin E, Dittrich H, Chappuis F, Ahnve S, Engler R, et al. Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction. Am J Cardiol 1988; 61: 1165-1171.
12. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2002; 106: 2145-2161.
13. Soto GE, Jones P, Weintraub WS, Krumholz HM, Spertus JA. Prognostic value of health status in patients with heart failure after acute myocardial infarction. Circulation 2004; 110: 546-551.
14. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 2000; 15: 2071-2078.
15. Moss AJ. Implantable cardioverter defibrillator therapy: the sickest patients benefit the most. Circulation 2000; 101: 1638-1640.
16. Holay MP, Janbandhu A, Javahirani A, Pandharipande MS, Suryawanshi SD. Clinical profile of acute myocardial infarction in elderly (prospective study). J Assoc Physicians India 2007; 55: 188-192.
17. Kiès P, Boersma E, Bax JJ, van der Burg AE, Bootsma M, van Erven L, et al. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study. J Cardiovasc Electrophysiol 2005; 16: 1049-1056.
18. Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, et al. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006; 47: 1739-1742.
19. Niu HX, Hua W, Zhang S, Sun X, Chen KP, Wang FZ, et al. Optimized cardiac resynchronization therapy in patients with congestive heart failure. Chin Med J 2007; 120: 605-607.
20. Hua W, Niu HX, Wang FZ, Zhang S, Chen KP, Chen X. Short-term effect of cardiac resynchronization therapy in patients with ischaemic or nonischaemic cardiomyopathy. Chin Med J 2006; 119: 1507-1510.